Jack Marshall, PhD
About Jack Marshall, PhD
Jack Marshall, PhD, is a Postdoctoral Research Fellow at the National Institutes of Health, focusing on Human Endogenous Retroviruses in Amyotrophic Lateral Sclerosis. He has a diverse academic background, including a PhD in Genetics and Molecular Biology from the University of Liverpool.
Work at National Institutes of Health
Jack Marshall has been a Postdoctoral Research Fellow at the National Institutes of Health (NIH) since 2021. His research is conducted at the National Institutes for Neurological Disorders and Stroke (NINDS), where he focuses on the role of Human Endogenous Retroviruses (HERVs) in Amyotrophic Lateral Sclerosis (ALS). This position marks a significant step in his academic career, allowing him to contribute to important neurological research.
Education and Expertise
Jack Marshall earned his Bachelor's degree in Biochemistry from the University of Liverpool from 2012 to 2015. He continued his studies at the same institution, obtaining a Master's degree in Biological Sciences with Honours (Biochemistry) in 2016. He further advanced his education by completing a Doctor of Philosophy (PhD) in Genetics and Molecular Biology at the University of Liverpool from 2016 to 2021. His educational background provides a strong foundation for his research in the field of neurology.
Previous Research Experience
Prior to his current role at NIH, Jack Marshall held several research positions. He worked as a PhD student and researcher at the University of Liverpool from 2016 to 2021. In 2019, he served as a Visiting Researcher at King's College London for one month. Additionally, he completed a three-month MRC Transition Award placement at the University of Sheffield in 2021. These experiences have contributed to his expertise in biological sciences and research methodologies.
Research Focus
Jack Marshall's current research at the NIH centers on Human Endogenous Retroviruses (HERVs) and their potential implications in Amyotrophic Lateral Sclerosis (ALS). This area of study is critical for understanding the underlying mechanisms of ALS and may lead to new therapeutic approaches. His work at NINDS reflects a commitment to advancing knowledge in neurological disorders.